Free Trial

Q2 2024 EPS Estimates for HNI Co. Decreased by Analyst (NYSE:HNI)

HNI Co. (NYSE:HNI - Free Report) - Investment analysts at Sidoti Csr reduced their Q2 2024 earnings per share estimates for shares of HNI in a note issued to investors on Tuesday, April 30th. Sidoti Csr analyst G. Burns now anticipates that the business services provider will post earnings of $0.60 per share for the quarter, down from their prior estimate of $0.63. The consensus estimate for HNI's current full-year earnings is $2.93 per share. Sidoti Csr also issued estimates for HNI's FY2024 earnings at $3.10 EPS, Q2 2025 earnings at $0.82 EPS, Q3 2025 earnings at $1.26 EPS and FY2025 earnings at $3.54 EPS.

Other equities research analysts have also issued reports about the company. StockNews.com lowered HNI from a "strong-buy" rating to a "buy" rating in a research note on Friday, March 8th. Benchmark upped their price target on HNI from $50.00 to $54.00 and gave the company a "buy" rating in a research report on Tuesday.

View Our Latest Analysis on HNI

HNI Stock Performance

Shares of HNI stock traded down $0.08 on Wednesday, hitting $41.87. The company had a trading volume of 301,454 shares, compared to its average volume of 258,083. The firm has a market cap of $1.98 billion, a P/E ratio of 31.01, a price-to-earnings-growth ratio of 1.22 and a beta of 0.86. The company has a 50-day moving average price of $43.25 and a 200-day moving average price of $41.03. The company has a quick ratio of 0.73, a current ratio of 1.29 and a debt-to-equity ratio of 0.61. HNI has a twelve month low of $24.81 and a twelve month high of $45.47.


HNI (NYSE:HNI - Get Free Report) last issued its quarterly earnings data on Monday, April 29th. The business services provider reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.19. The business had revenue of $588.00 million during the quarter, compared to analysts' expectations of $574.56 million. HNI had a return on equity of 17.75% and a net margin of 2.57%. The company's revenue for the quarter was up 22.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.13 EPS.

HNI Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 6th. Investors of record on Monday, February 26th were given a $0.32 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.28 annualized dividend and a yield of 3.06%. HNI's payout ratio is 94.81%.

Insider Buying and Selling

In other HNI news, Director Mary A. Bell sold 2,898 shares of the company's stock in a transaction on Friday, March 15th. The stock was sold at an average price of $43.13, for a total transaction of $124,990.74. Following the transaction, the director now directly owns 76,183 shares in the company, valued at $3,285,772.79. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HNI news, Director Miguel M. Calado sold 2,500 shares of the company's stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $42.99, for a total transaction of $107,475.00. Following the transaction, the director now directly owns 36,988 shares in the company, valued at $1,590,114.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mary A. Bell sold 2,898 shares of the company's stock in a transaction on Friday, March 15th. The stock was sold at an average price of $43.13, for a total value of $124,990.74. Following the transaction, the director now owns 76,183 shares in the company, valued at $3,285,772.79. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,374 shares of company stock worth $749,534. Company insiders own 3.36% of the company's stock.

Institutional Trading of HNI

Several hedge funds have recently modified their holdings of HNI. USA Financial Formulas acquired a new stake in shares of HNI in the fourth quarter valued at $25,000. FinTrust Capital Advisors LLC acquired a new stake in shares of HNI in the fourth quarter valued at $42,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of HNI in the third quarter valued at $56,000. Northwest Financial Advisors purchased a new position in HNI in the fourth quarter valued at $134,000. Finally, Hsbc Holdings PLC purchased a new position in HNI in the third quarter valued at $207,000. 75.26% of the stock is currently owned by institutional investors and hedge funds.

HNI Company Profile

(Get Free Report)

HNI Corporation, together with its subsidiaries, engages in the manufacture, sale, and marketing of workplace furnishings and residential building products primarily in the United States and Canada. The company operates through two segments, Workplace Furnishings and Residential Building Products. The Workplace Furnishings segment offers a range of commercial and home office furniture, including panel-based and freestanding furniture systems, seating, storage, benching, tables, architectural products, and ancillary and hospitality products, as well as social collaborative items under the HON, Allsteel, Beyond, Gunlocke, HBF, HBF Textiles, HNI India, Kimball, National, Etc., Interwoven, David Edward, Kimball Hospitality, and D'style brands.

Further Reading

Earnings History and Estimates for HNI (NYSE:HNI)

Should you invest $1,000 in HNI right now?

Before you consider HNI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HNI wasn't on the list.

While HNI currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: